STRATACLONE, created in 2008 (United States), from 274 sister brands and 2617 competing brands. STRATACLONE is a brand of Agilent Technologies, Inc., listed on the stock exchange of New York. STRATACLONE belongs to the Medical Diagnostics & Research business sector.
Investment simulator :
Portfolio valuation
Agilent Technologies, Inc.
(STRATACLONE)
over 5 years*
USD 252.82